Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News report.faq_name
On This Report

Prostate Cancer Market Size & Share, By Drug Class (Hormonal ADT, AR-Directed Therapies, Cytotoxic agents, Bone metastases therapeutic vaccines, PARP inhibitors, Kinase inhibitors, PSMA-targeted radioligands), Distribution Channel (Hospital Pharmacies, Drug store & Retail pharmacies, Online pharmacies) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034

Report ID: FBI 4983| Published Date: Jan-2025| Format: PDF, Excel
Market Outlook

Market Size and Growth Outlook

Prostate Cancer Market size is anticipated to grow significantly, reaching USD 26.41 billion by 2034, up from USD 11.79 billion. This growth represents a CAGR of over 8.4%, with a revenue forecast of USD 12.68 billion for 2025.

Base Year Value (2024)
USD 11.79 billion
CAGR (2025-2034)
8.4%
Forecast Year Value (2034)
USD 26.41 billion
Historical Data Period
2019-2024
Largest Region
North America
Forecast Period
2025-2034

Get more details on this report

Request Free Sample Report
SNAPSHOT

Prostate Cancer Market Intelligence Snapshot

Regional Market Dynamics

Segment Momentum

Market Expansion Drivers

Leading Market Participants

FORECAST SNAPSHOT

Global Market Forecast Snapshot

Market Outlook

Regional and Segment Outlook

REGIONAL FORECAST

Regional Demand Dynamics

Polymer Modified Bitumen Market
Largest Region
North America
XX% Market Share in 2024
North America: The prostate cancer market size in North America, specifically in the United States and Canada, is expected to witness steady growth due to increasing prevalence of prostate cancer in the region. The availability of advanced diagnostic and treatment options, along with favorable reimbursement policies, is contributing to the growth of the market in North America. Asia Pacific: In Asia Pacific, countries such as China, Japan, and South Korea are experiencing a rise in the incidence of prostate cancer. This is primarily attributed to factors such as aging population, changing lifestyle patterns, and increasing awareness about early diagnosis and treatment of the disease. The market for prostate cancer in Asia Pacific is expected to witness significant growth in the coming years. Europe: The prostate cancer market in Europe, particularly in countries like the United Kingdom, Germany, and France, is witnessing rapid advancements in terms of diagnosis and treatment options. The increasing investments in research and development activities, along with favorable healthcare policies, are driving the growth of the market in Europe. The rising prevalence of prostate cancer in the region is also contributing to the market growth.
SEGMENT ANALYSIS

Segment Leadership and Growth Trends

Go beyond the chart, access full insights & data tables

Request Free Sample Report
Prostate Cancer Market, By Drug Class: Hormonal ADT: The hormonal ADT drug class continues to be a predominant treatment option for prostate cancer, as it works by reducing levels of testosterone in the body to slow down cancer growth. AR-Directed Therapies: AR-directed therapies target the androgen receptor, a key driver of prostate cancer growth. These drugs have shown promising results in advanced prostate cancer cases. Cytotoxic agents: Cytotoxic agents are chemotherapy drugs that target and destroy rapidly dividing cancer cells. They are often used in combination with other therapies for more aggressive forms of prostate cancer. Bone metastases therapeutic vaccines: Therapeutic vaccines target specific antigens associated with prostate cancer cells and stimulate the immune system to recognize and attack these cells, particularly those that have spread to the bones. PARP inhibitors: PARP inhibitors are a newer class of drugs that target specific DNA repair mechanisms in cancer cells. They have shown potential in treating prostate cancer with certain genetic mutations. Kinase inhibitors: Kinase inhibitors block specific enzymes involved in cancer cell growth and proliferation. They are being evaluated for their potential efficacy in treating advanced prostate cancer. PSMA-targeted radioligands: PSMA-targeted radioligands deliver radiation directly to prostate cancer cells that express the PSMA protein. This targeted approach can help spare healthy tissues and improve treatment outcomes. Distribution Channel: Hospital Pharmacies: Hospital pharmacies play a critical role in providing patients with access to specialized medications and treatments for prostate cancer. They often work closely with healthcare providers to ensure proper administration and monitoring. Drug store & Retail pharmacies: Drug store and retail pharmacies offer convenience and accessibility for patients seeking prescription medications for prostate cancer. They may also provide counseling and support services. Online pharmacies: Online pharmacies have gained popularity for their convenience and ability to deliver medications directly to patients' homes. They provide a convenient option for those who may have difficulty accessing traditional brick-and-mortar pharmacies.
Competitive Landscape

Competitive Landscape and Market Positioning

Top Market Players: 1. Astellas Pharma Inc. 2. Johnson & Johnson 3. AstraZeneca plc 4. Sanofi 5. Bayer AG 6. Pfizer Inc. 7. Bristol-Myers Squibb Company 8. GlaxoSmithKline plc 9. Novartis AG 10. AbbVie Inc. The competitive landscape in the Prostate Cancer Market is intense, with numerous companies competing for market share through innovative treatments, strategic partnerships, and aggressive marketing tactics. The market players listed above are some of the major players in the global prostate cancer market, each offering a range of products and services aimed at addressing the needs of patients and healthcare providers.
Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Prostate Cancer Market — Custom Segments

Segment Sub-Segment
No segment data available.

Prostate Cancer Market — Custom

Custom Chapter Custom Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
Frequently Asked Questions

Testimonials

Our Clients

"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."

Quality Assurance Manager

"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."

R&D Manager

"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."

Senior Marketing Manager
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →